Clinical trial

Changing of Prostate Specific Antigen Value in Patients With Covid-19

NCT05009186

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-04-01

PhaseNA

Study timeline

Study start (actual)2020-04-01Date precision: day

Registry last updated2021-08-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Covid19unresolved

Prostate Specific Antigenunresolved

Interventions

PSA valueOTHER

Sponsors & collaborators

Saglik Bilimleri Universitesilead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05009186 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.